SNY - Sanofi
52.32
-1.220 -2.332%
Share volume: 5,488,691
Last Updated: 04-25-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.10%
PREVIOUS CLOSE
CHG
CHG%
$53.54
-1.22
-0.02%
Fundamental analysis
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Performance
5 Days
0.91%
1 Month
-4.72%
3 Months
-1.91%
6 Months
-3.75%
1 Year
6.58%
2 Year
-6.72%
Key data
Stock price
$52.32
DAY RANGE
$52.22 - $52.92
52 WEEK RANGE
$45.80 - $60.12
52 WEEK CHANGE
$6.58
DIVIDEND
$2.0369
EX-DIVIDEND DATE
05-09-2024
NEXT EARNINGS DATE
07-24-2025
Company detail
CEO: Paul Hudson
Region: US
Website: sanofi.com
Employees: 91,600
IPO year: 2002
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: sanofi.com
Employees: 91,600
IPO year: 2002
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation.
Recent news
